Login / Signup

Exclusion of enrolled participants in randomised controlled trials: what to do with ineligible participants?

Andrea Mary RehmanRashida FerrandElizabeth AllenVictoria SimmsGrace McHughHelen Anne Weiss
Published in: BMJ open (2020)
The decision, by senior investigators, on whether to exclude enrolled participants, should reflect issues of safety, treatment efficacy, statistical power and measurement error. As long as decisions are made prior to finalising the statistical analysis plan for the trial, the risk of exclusions creating bias should be minimal. The decision taken should be transparently reported and a sensitivity analysis can present the opposite decision.
Keyphrases
  • decision making
  • study protocol
  • phase iii
  • phase ii
  • combination therapy
  • open label
  • replacement therapy
  • data analysis
  • smoking cessation